These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11322935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trifluoperazine inhibits spreading and migration of cells in culture.
    Connor CG, Brady RC, Brownstein BL.
    J Cell Physiol; 1981 Sep; 108(3):299-307. PubMed ID: 7287823
    [Abstract] [Full Text] [Related]

  • 4. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
    Papadopoulos V, Widmaier EP, Hall PF.
    Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
    [Abstract] [Full Text] [Related]

  • 5. Induction of early growth response-1 gene expression by calmodulin antagonist trifluoperazine through the activation of Elk-1 in human fibrosarcoma HT1080 cells.
    Shin SY, Kim SY, Kim JH, Min DS, Ko J, Kang UG, Kim YS, Kwon TK, Han MY, Kim YH, Lee YH.
    J Biol Chem; 2001 Mar 16; 276(11):7797-805. PubMed ID: 11121417
    [Abstract] [Full Text] [Related]

  • 6. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
    Kang S, Hong J, Lee JM, Moon HE, Jeon B, Choi J, Yoon NA, Paek SH, Roh EJ, Lee CJ, Kang SS.
    Mol Cancer Ther; 2017 Jan 16; 16(1):217-227. PubMed ID: 28062709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships of phenothiazines in inhibiting lymphocyte motility as determined by a novel flow cytometric assay.
    Matthews N, Franklin RJ, Kendrick DA.
    Biochem Pharmacol; 1995 Sep 28; 50(7):1053-61. PubMed ID: 7575661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of secretion of rat calcitonin by calmodulin inhibitors.
    Cooper CW, Borosky SA.
    Calcif Tissue Int; 1986 Feb 28; 38(2):103-8. PubMed ID: 3082492
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of calmodulin blockers on membrane potential, potassium permeability and lymphocyte mitogenesis].
    Gukovskaia AS, Zinchenko VP, Astashkin EI.
    Biokhimiia; 1985 May 28; 50(5):786-94. PubMed ID: 3924125
    [Abstract] [Full Text] [Related]

  • 17. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS, Hait WN, Kennedy KA, Braun ID, Meandzija B.
    Mol Pharmacol; 1985 Mar 28; 27(3):387-93. PubMed ID: 2579318
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of calmodulin inhibitors of the adenylate cyclase system.
    Okruhlicová L, Slezák J.
    Physiol Bohemoslov; 1990 Mar 28; 39(2):151-5. PubMed ID: 2168569
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.